These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8866037)

  • 21. Comparison of the effects of a new conjugated oral estrogen, estradiol-3beta-glucoside, with oral micronized 17beta-estradiol in postmenopausal women.
    Sweeney AT; Tangpricha V; Weinberg J; Malabanan AO; Chimeh FN; Holick MF
    Transl Res; 2006 Oct; 148(4):164-70. PubMed ID: 17002918
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
    Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term effects of oral and transdermal hormone replacement therapy on plasma homocysteine levels.
    Chiantera V; Sarti CD; Fornaro F; Farzati A; De Franciscis P; Sepe E; Borrelli AL; Colacurci N
    Menopause; 2003; 10(4):286-91. PubMed ID: 12851511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estradiol in micellar nanoparticles: the efficacy and safety of a novel transdermal drug-delivery technology in the management of moderate to severe vasomotor symptoms.
    Simon JA;
    Menopause; 2006; 13(2):222-31. PubMed ID: 16645536
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of pharmacokinetic profiles of a 17 beta-estradiol gel 0.6 mg/g (Gelestra) with a transdermal delivery system (Estraderm TTS 50) in postmenopausal women at steady state.
    Paoletti AM; Pilia I; Nannipieri F; Bigini C; Melis GB
    Maturitas; 2001 Dec; 40(3):203-9. PubMed ID: 11731181
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An evaluation of bioequivalence of two 7-day 17beta-estradiol transdermal delivery systems by anatomical site.
    Harrison LL; Harari D
    J Clin Pharmacol; 2002 Oct; 42(10):1134-41. PubMed ID: 12362928
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Absorption, bioavailability, and partner transfer of estradiol from a topical emulsion.
    Taylor MB; Gutierrez MJ
    Pharmacotherapy; 2008 Jun; 28(6):712-8. PubMed ID: 18503399
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women.
    Vehkavaara S; Silveira A; Hakala-Ala-Pietilä T; Virkamäki A; Hovatta O; Hamsten A; Taskinen MR; Yki-Järvinen H
    Thromb Haemost; 2001 Apr; 85(4):619-25. PubMed ID: 11341495
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of skin-to-skin contact, application site washing, and sunscreen use on the pharmacokinetics of estradiol from a metered-dose transdermal spray.
    Schumacher RJ; Gattermeir DJ; Peterson CA; Wisdom C; Day WW
    Menopause; 2009; 16(1):177-83. PubMed ID: 18779758
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of transdermal and vaginal estrogen therapy on markers of postmenopausal estrogen status.
    Gupta P; Ozel B; Stanczyk FZ; Felix JC; Mishell DR
    Menopause; 2008; 15(1):94-7. PubMed ID: 17882008
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative bioequivalence studies with Estradot and Menorest transdermal systems.
    Hossain M; Quebe-Fehling E; Sergejew T; Schmidt G; Skerjanec A; Cohen A; Krinsky L; Ibarra de Palacios P
    Maturitas; 2003 Nov; 46(3):187-98. PubMed ID: 14585521
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low dose of transdermal estradiol gel for treatment of symptomatic postmenopausal women: a randomized controlled trial.
    Simon JA; Bouchard C; Waldbaum A; Utian W; Zborowski J; Snabes MC
    Obstet Gynecol; 2007 Mar; 109(3):588-96. PubMed ID: 17329509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Single-dose pharmacokinetics of sublingual versus oral administration of micronized 17 beta-estradiol.
    Price TM; Blauer KL; Hansen M; Stanczyk F; Lobo R; Bates GW
    Obstet Gynecol; 1997 Mar; 89(3):340-5. PubMed ID: 9052581
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of zonisamide on the pharmacokinetics and pharmacodynamics of a combination ethinyl estradiol-norethindrone oral contraceptive in healthy women.
    Griffith SG; Dai Y
    Clin Ther; 2004 Dec; 26(12):2056-65. PubMed ID: 15823769
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum concentrations of 17beta-estradiol and estrone after multiple-dose administration of percutaneous estradiol gel in symptomatic menopausal women.
    Brennan JJ; Lu Z; Whitman M; Stafiniak P; van der Hoop RG
    Ther Drug Monit; 2001 Apr; 23(2):134-8. PubMed ID: 11294513
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The pharmacokinetics of intravenous estradiol--a preliminary study.
    White CM; Ferraro-Borgida MJ; Fossati AT; McGill CC; Ahlberg AW; Feng YJ; Heller GV; Chow MS
    Pharmacotherapy; 1998; 18(6):1343-6. PubMed ID: 9855336
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the pharmacokinetics of 17 beta-estradiol after a single 4-day application of Oesclim 50, Oesclim 100, and Vivelle 0.05 (Menorest 50) transdermal delivery systems.
    Guichard JP; Sauron R; Jones AB
    J Clin Pharmacol; 1999 Aug; 39(8):811-6. PubMed ID: 10434233
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 17Beta-estradiol delivered by three different matrix patches 50 microg/day: a three way cross-over study in 21 postmenopausal women.
    Rohr UD; Nauert C; Stehle B
    Maturitas; 1999 Sep; 33(1):45-58. PubMed ID: 10585173
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transdermal delivery of estradiol in postmenopausal women with a novel topical aerosol.
    Morgan TM; O'Sullivan HM; Reed BL; Finnin BC
    J Pharm Sci; 1998 Oct; 87(10):1226-8. PubMed ID: 9758681
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum estrogen level after hormone replacement therapy and body mass index in postmenopausal and bilaterally ovariectomized women.
    Yasui T; Uemura H; Umino Y; Takikawa M; Saito S; Kuwahara A; Matsuzaki T; Maegawa M; Furumoto H; Miura M; Irahara M
    Maturitas; 2005 Jan; 50(1):19-29. PubMed ID: 15590210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.